Elektronisk udgave - Sundhedsstyrelsen

Thus, when making decisions as to whether the range of patientsbeing offered the treatment should be widened, aspects otherthan the purely clinical and financial aspects should be taken intoaccount.There may be factors other than those described in thereport which individual county authorities might wish to considerwhen deciding whether or not to offer interferon beta treatment tomore patients. In the light of the patients’ freedom of choice overhospitals, DIHTA hereby recommends that the county authoritiesshould coordinate their decisions in this field.ix